Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of glycemic fluctuations with NPH insulin vs insulin glargine using continuous glucose monitoring
2006-000122-31Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Primary endpoint: Glycemic fluctuations. Started Mar 2006; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-000122-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000122-31.